{"id":"https://openalex.org/W4310108902","doi":"https://doi.org/10.1182/blood-2022-165675","title":"A Novel Inhibitor of FLT3 and Its Drug-Resistant Mutants with Superior Activity to Gilteritinib in Molm-13 Preclinical Acute Myeloid Leukemia Xenograft Model","display_name":"A Novel Inhibitor of FLT3 and Its Drug-Resistant Mutants with Superior Activity to Gilteritinib in Molm-13 Preclinical Acute Myeloid Leukemia Xenograft Model","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310108902","doi":"https://doi.org/10.1182/blood-2022-165675"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-165675","doi":"https://doi.org/10.1182/blood-2022-165675","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-165675","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004456259","display_name":"Ola A. Elgamal","orcid":"https://orcid.org/0000-0001-5011-3909","observed_orcids":["https://orcid.org/0000-0001-5011-3909"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ola A Elgamal","raw_affiliation_strings":["1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010571123","display_name":"James R. Lerma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James R Lerma","raw_affiliation_strings":["1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017914762","display_name":"Allison Mullaney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Mullaney","raw_affiliation_strings":["2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079861189","display_name":"Emily H. Stahl","orcid":"https://orcid.org/0000-0002-4329-8885","observed_orcids":["https://orcid.org/0000-0002-4329-8885"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Stahl","raw_affiliation_strings":["2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064630084","display_name":"Blaise Stearns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Blaise Stearns","raw_affiliation_strings":["1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003667568","display_name":"Andrew J. W. Orry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111989","display_name":"Molsoft (United States)","ror":"https://ror.org/024712k05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Orry","raw_affiliation_strings":["3MolSoft LLC, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3MolSoft LLC, San Diego,","institution_ids":["https://openalex.org/I4210111989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111895581","display_name":"Polo Chun\u2010Hung Lam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111989","display_name":"Molsoft (United States)","ror":"https://ror.org/024712k05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Polo Chun-Hung Lam","raw_affiliation_strings":["3MolSoft LLC, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3MolSoft LLC, San Diego,","institution_ids":["https://openalex.org/I4210111989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064101943","display_name":"Ruben A Abagyan","orcid":"https://orcid.org/0000-0001-9309-2976","observed_orcids":["https://orcid.org/0000-0001-9309-2976"]},"institutions":[{"id":"https://openalex.org/I4210111989","display_name":"Molsoft (United States)","ror":"https://ror.org/024712k05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben Abagyan","raw_affiliation_strings":["3MolSoft LLC, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3MolSoft LLC, San Diego,","institution_ids":["https://openalex.org/I4210111989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113214946","display_name":"Alexei O. Pushechnikov","orcid":"https://orcid.org/0000-0003-4404-1851","observed_orcids":["https://orcid.org/0000-0003-4404-1851"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexei Pushechnikov","raw_affiliation_strings":["4Eilean Therapeutics, Philadelphia,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Eilean Therapeutics, Philadelphia,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002152420","display_name":"Nikolay Savchuk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikolay Savchuk","raw_affiliation_strings":["4Eilean Therapeutics, Philadelphia,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Eilean Therapeutics, Philadelphia,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021001457","display_name":"Volodymyr M. Kysil","orcid":"https://orcid.org/0009-0003-9387-6609","observed_orcids":["https://orcid.org/0009-0003-9387-6609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Volodymyr Kysil","raw_affiliation_strings":["4Eilean Therapeutics, Philadelphia,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Eilean Therapeutics, Philadelphia,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070956637","display_name":"Hovhannes J. Gukasyan","orcid":"https://orcid.org/0000-0002-2364-3514","observed_orcids":["https://orcid.org/0000-0002-2364-3514"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hovhannes Gukasyan","raw_affiliation_strings":["4Eilean Therapeutics, Philadelphia,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Eilean Therapeutics, Philadelphia,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018544847","display_name":"Iain D. Dukes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iain Dukes","raw_affiliation_strings":["4Eilean Therapeutics, Philadelphia,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Eilean Therapeutics, Philadelphia,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043150841","display_name":"Oleg D. Mitkin","orcid":"https://orcid.org/0000-0003-2296-1980","observed_orcids":["https://orcid.org/0000-0003-2296-1980"]},"institutions":[{"id":"https://openalex.org/I4210129383","display_name":"ChemDiv (United States)","ror":"https://ror.org/0386d9c06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129383"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oleg Mitkin","raw_affiliation_strings":["5ChemDiv Inc, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5ChemDiv Inc, San Diego,","institution_ids":["https://openalex.org/I4210129383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046028117","display_name":"Ruben N. Karapetian","orcid":"https://orcid.org/0000-0002-7405-746X","observed_orcids":["https://orcid.org/0000-0002-7405-746X"]},"institutions":[{"id":"https://openalex.org/I4210129383","display_name":"ChemDiv (United States)","ror":"https://ror.org/0386d9c06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129383"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben Karapetian","raw_affiliation_strings":["5ChemDiv Inc, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5ChemDiv Inc, San Diego,","institution_ids":["https://openalex.org/I4210129383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091214508","display_name":"Alexei Riakhovskii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129383","display_name":"ChemDiv (United States)","ror":"https://ror.org/0386d9c06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129383"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexei Riakhovskii","raw_affiliation_strings":["5ChemDiv Inc, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5ChemDiv Inc, San Diego,","institution_ids":["https://openalex.org/I4210129383"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Elena Bulanova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129383","display_name":"ChemDiv (United States)","ror":"https://ror.org/0386d9c06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129383"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Bulanova","raw_affiliation_strings":["5ChemDiv Inc, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5ChemDiv Inc, San Diego,","institution_ids":["https://openalex.org/I4210129383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029931682","display_name":"Vladislav Z. Parchinsky","orcid":"https://orcid.org/0000-0001-9572-2409","observed_orcids":["https://orcid.org/0000-0001-9572-2409"]},"institutions":[{"id":"https://openalex.org/I4210129383","display_name":"ChemDiv (United States)","ror":"https://ror.org/0386d9c06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129383"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vladislav Parchinsky","raw_affiliation_strings":["5ChemDiv Inc, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5ChemDiv Inc, San Diego,","institution_ids":["https://openalex.org/I4210129383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033183874","display_name":"Alexandre V. Ivachtchenko","orcid":"https://orcid.org/0000-0002-9626-4822","observed_orcids":["https://orcid.org/0000-0002-9626-4822","https://orcid.org/0000-0003-1586-7910"]},"institutions":[{"id":"https://openalex.org/I4210129383","display_name":"ChemDiv (United States)","ror":"https://ror.org/0386d9c06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129383"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre Ivachtchenko","raw_affiliation_strings":["5ChemDiv Inc, San Diego,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5ChemDiv Inc, San Diego,","institution_ids":["https://openalex.org/I4210129383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharyn Baker","raw_affiliation_strings":["6Division of Pharmaceutics and Pharmacology, College of Pharmacy, Comprehensive Cancer Center, The Ohio State University, Columbus,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Division of Pharmaceutics and Pharmacology, College of Pharmacy, Comprehensive Cancer Center, The Ohio State University, Columbus,","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026993490","display_name":"Erin K. Hertlein","orcid":"https://orcid.org/0000-0001-8493-5679","observed_orcids":["https://orcid.org/0000-0001-8493-5679"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Hertlein","raw_affiliation_strings":["1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069774776","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0002-8778-1000","observed_orcids":["https://orcid.org/0000-0002-8778-1000"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":["1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24688909,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"3352","last_page":"3353"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.7670000195503235},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.8450000286102295},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6579999923706055},{"id":"https://openalex.org/keywords/flt3-tyrosine-kinase-domain-mutation","display_name":"FLT3 tyrosine kinase domain mutation","score":0.8399999737739563},{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":0.6959999799728394},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.7120000123977661},{"id":"https://openalex.org/keywords/kinase-selectivity-profiling","display_name":"kinase selectivity profiling","score":0.597000002861023}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6636819243431091},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5496811866760254},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47044697403907776},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.46160808205604553},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45592546463012695},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.451985239982605},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4327161908149719},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4215778708457947},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2205699384212494}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-165675","doi":"https://doi.org/10.1182/blood-2022-165675","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-165675","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410809231","https://openalex.org/W3080171134","https://openalex.org/W4282922160","https://openalex.org/W3044995044","https://openalex.org/W7111834679","https://openalex.org/W2912080691","https://openalex.org/W4310342538","https://openalex.org/W4389001348","https://openalex.org/W3196289928","https://openalex.org/W2030990783"],"abstract_inverted_index":{"Acute":[0],"Myeloid":[1],"Leukemia":[2],"(AML)":[3],"is":[4,40,63,109,165,199,245,297,477],"a":[5,22,182,200,267,298,453,502,533],"complex":[6],"heterogenous":[7],"disease":[8],"characterized":[9],"by":[10,21],"the":[11,56,134,145,151,236,275,384,395,480,518],"aberrant":[12],"growth":[13],"of":[14,24,105,115,128,136,153,173,292,301,341,355,358,376,398,421,426,435,458,506,520],"undifferentiated":[15],"myeloid":[16],"progenitor":[17],"cells":[18],"typically":[19],"driven":[20],"combination":[23,72],"epigenetic":[25],"and":[26,45,85,87,112,210,257,322,338,349,428,432,440,455,465,535],"signaling":[27,158,303],"mutations.":[28,196,261],"In":[29,223,449],"particular,":[30],"fms-like":[31],"tyrosine":[32,137,184,467],"kinase":[33,138,185,204,468],"3":[34],"(Flt3)":[35],"internal":[36,462],"tandem":[37,463],"duplication":[38,464],"(FLT3-ITD)":[39],"associated":[41],"with":[42,73,102,119,187,284,382,472],"poor":[43],"relapse-free":[44],"overall":[46,367,396],"survival.":[47],"Several":[48],"FLT3":[49,68,93,120,131,191,249,259,485],"inhibitors":[50,78,121,132,171],"have":[51],"been":[52,100],"developed":[53],"such":[54,79,143,160],"as":[55,80,144,161,206],"first":[57],"generation":[58,77],"multikinase":[59],"inhibitor":[60,186,300,457,486],"Midostaurin":[61],"which":[62,476],"approved":[64,90,484],"for":[65,91],"newly":[66],"diagnosed":[67],"mutant":[69,94,192,233,309],"AML":[70,310,491,528],"in":[71,156,207,231,266,307,373,389,488,492,497,524],"induction":[74],"chemotherapy.":[75],"Second":[76],"gilteritinib":[81,427,443,487,523],"are":[82,88],"more":[83],"selective":[84,202],"potent":[86,246,299,456,482],"also":[89],"relapsed/refractory":[92],"AML.":[95],"Although":[96],"initial":[97,225],"response":[98],"has":[99,218],"positive":[101],"this":[103,264],"class":[104],"agents,":[106],"prolonged":[107],"remission":[108],"rarely":[110],"achieved,":[111],"diverse":[113],"mechanisms":[114,127],"resistance":[116,129,176],"often":[117],"arise":[118],"representing":[122],"an":[123,489,525],"ongoing":[124],"challenge.":[125],"Common":[126],"to":[130,167,305,393,401,410,442,479,522],"includes":[133],"acquisition":[135],"domain":[139,469],"(TKD)":[140,470],"secondary":[141],"mutations":[142,155,277],"gatekeeper":[146,538],"F691L":[147,281],"TKD":[148,195,260,276,537],"mutation,":[149],"or":[150,280,283,418,423],"emergence":[152],"additional":[154],"alternative":[157],"pathways":[159],"RAS/MAPK.":[162],"Thus,":[163],"it":[164,217],"important":[166],"continue":[168],"developing":[169],"novel":[170,183,454],"capable":[172],"circumventing":[174],"these":[175],"mechanisms.":[177],"Herein":[178],"we":[179,287,317,380,451],"describe":[180,452],"2082-0047,":[181],"sub-nanomolar":[188],"potency":[189],"against":[190,247],"AML,":[193],"including":[194,460],"Compound":[197],"2082-0047":[198,227,244,296,325,399,422,436,521],"highly":[201],"pan-FLT3":[203],"inhibitor,":[205],"both":[208,461,532],"scanMAX":[209],"KdELECT":[211],"KINOMEscan\u2122":[212,237],"Profiling":[213,238],"assays":[214],"(Eurofins":[215],"DiscoverX)":[216],"shown":[219],"400-1000":[220],"fold":[221],"selectivity.":[222],"our":[224,345,363],"screening,":[226],"was":[228],"only":[229],"effective":[230],"FLT3-ITD":[232,302,308],"cells,":[234],"however":[235],"data":[239,265],"described":[240],"above":[241],"demonstrates":[242],"that":[243,295,324,430],"FLT3,":[248,459],"ITD,":[250],"D835H,":[251],"D835V,":[252,254],"D835Y,":[253,278],"K663Q,":[255],"N841I,":[256],"R834Q":[258],"We":[262,403],"confirmed":[263,288,501],"cellular":[268],"assay":[269],"using":[270,289,383],"BaF3":[271],"cell":[272,311],"lines":[273],"expressing":[274],"D835H":[279],"alone":[282],"Flt3-ITD.":[285],"Next,":[286,344],"immunoblot":[290],"analysis":[291],"phosphorylated":[293],"Flt3":[294],"(superior":[304],"gilteritinib)":[306],"lines.":[312],"Using":[313],"wildtype":[314],"B6":[315],"mice,":[316],"conducted":[318],"pharmacokinetic":[319],"(PK)":[320],"studies":[321,352,365,500,514],"found":[323,429],"had":[326,339],"79":[327],"%":[328],"oral":[329,413],"bioavailability,":[330],"achieved":[331],"1.2":[332],"\u03bc\u039c":[333],"Cmax":[334],"after":[335],"4":[336],"hours,":[337],"half-life":[340],"4.7":[342],"hours.":[343],"absorption,":[346],"distribution,":[347],"metabolism":[348],"excretion":[350],"(ADME)":[351],"showed":[353],"lack":[354],"CYP":[356],"inhibition":[357],"major":[359],"human":[360],"isoforms.":[361],"Overall,":[362],"PK":[364],"demonstrated":[366],"favorable":[368],"drug":[369],"like":[370],"properties":[371],"enabling":[372,513],"vivo":[374,493,498],"investigation":[375],"therapeutic":[377,504],"activity.":[378],"Therefore,":[379],"proceeded":[381],"MOLM-13":[385],"disseminated":[386],"xenograft":[387],"model":[388,530],"NCG":[390],"recipient":[391],"mice":[392,405],"determine":[394],"survival":[397],"compared":[400],"gilteritinib.":[402],"enrolled":[404],"10":[406,431],"days":[407],"post":[408],"engraftment":[409],"receive":[411],"daily":[412],"vehicle,":[414],"3,":[415],"10,":[416],"20":[417,433],"30":[419,424,445],"mg/kg":[420,425,434,446],"were":[437],"well":[438],"tolerated":[439],"superior":[441,478],"at":[444],"(Figure":[447],"1).":[448],"summary,":[450],"drug-resistant":[466],"mutants,":[471],"promising":[473],"preclinical":[474],"activity":[475],"most":[481],"FDA":[483],"aggressive":[490],"model.":[494],"Our":[495],"non-GLP":[496],"safety":[499],"broad":[503],"window":[505],"2082-0047.":[507],"Ongoing":[508],"Investigational":[509],"New":[510],"Drug":[511],"(IND)":[512],"will":[515],"include":[516],"comparing":[517],"effect":[519],"immunocompetent":[526],"syngeneic":[527],"murine":[529],"harboring":[531],"Flt3-ITD":[534],"F691":[536],"mutation.":[539],"Figure":[540],"1View":[541,544],"largeDownload":[542,545],"PPTFigure":[543],"PPT":[546],"Close":[547],"modal":[548]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-30T00:00:00"}